Surge
Surge offers an end-to-end platform to decrypt the immune system. We work on improving prediction of numerous medical outcomes such as surgical complications and implant rejection.
Surge operates in medtech based in Paris, France, founded in 2022.
Profile
End-to-end platform for analyzing patients' immune profiles.
Its activity falls under medtech; the profile below is assembled from public directory data.
The company is recorded as being based in Paris, France.
Directory data places it at the Plug and Play accelerated startup stage.
| Sector | Medtech |
|---|---|
| Headquarters | Paris, France |
| Country | France |
| Founded | 2022 |
| Stage | Plug and Play accelerated startup |
Website: surge.care
Browse related
Sign in to view the contact information we hold for Surge.
Create a free account
Create a free account